ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
SAB Biotherapeutics Inc

SAB Biotherapeutics Inc (SABS)

2.19
0.02
(0.92%)
Closed February 02 3:00PM
2.14
-0.05
(-2.28%)
After Hours: 6:57PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.16M581k86k1.27M305k945k263k0
Operating Income -7.86M-7.4M-6.48M-5.32M-18.87M-11.39M-10.2M-11.31M
Pre Tax Income -7.85M-7.35M-6.88M-5.1M-22.86M-5.03M-7.34M-10.35M
Net Income -7.88M-7.35M-6.88M-5.1M-22.86M-5.03M-7.34M-10.35M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.83M-7.4M-6.48M-5.23M-18.54M-10.92M-9.83M-10.56M
EBITDA -6.96M-6.51M-5.61M-4.36M-17.95M-9.43M-9.17M-10.36M
Year End December 30 2023 2020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 060.88M23.9M2.24M
Operating Income -9k-13.39M-28.92M-38.08M
Pre Tax Income -9k-17.15M-18.72M-42.19M
Net Income -9k-17.15M-18.74M-42.19M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.003-0.394-0.436-0.806
EBIT -9k-13.39M-28.88M-37.64M
EBITDA -9k-11.91M-25.75M-34.42M